As of May 22
| +0.02 / +1.36%|
The 1 analysts offering 12-month price forecasts for Avadel Pharmaceuticals PLC have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +34.23% increase from the last price of 1.49.
The current consensus among 2 polled investment analysts is to Hold stock in Avadel Pharmaceuticals PLC. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.